Orchid Pharma allots 4,45,86,052 shares to Dhanuka Laboratories holders in amalgamation
Orchid Pharma · Pharmaceuticals & Biotechnology
Key highlights
- Board on August 01, 2026 approved allotment of 4,45,86,052 equity shares of Rs. 10 each to eligible shareholders of Dhanuka Laboratories Limited, record date July 23, 2026
- Shares are proposed to be listed on BSE Limited and National Stock Exchange of India Limited, ranking pari-passu with existing equity shares
- Paid up share capital after allotment and cancellation of cross holding is Rs. 59,88,52,000 divided into 5,98,85,200 shares of Rs. 10 each
Why it's rated notable: The allotment of 4,45,86,052 shares to Dhanuka Laboratories shareholders under the amalgamation scheme states no value, so it is sized as medium under the rule for amalgamations with no value.
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Board Meeting Outcome for Outcome Of Board Meeting Held On August 01, 2026
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Orchid Pharma
- Fundraise / allotmentOrchid Pharma Limited QIP proceeds utilization and monitoring report for Q2 FY 2026-27
- Fundraise / allotmentNotableOrchid Pharma Ltd QIP monitoring report for quarter ended June 30, 2026
- Acquisition / mergerNotableOrchid Pharma announces effective date of Scheme of Amalgamation with Dhanuka Laboratories
- Acquisition / mergerNotableOrchid Pharma Limited announces NCLT approval for merger with Dhanuka Laboratories
- Acquisition / mergerNotableOrchid Pharma Limited announces NCLT approval for amalgamation with Dhanuka Laboratories
Other fundraise / allotment filings this fortnight
- Fundraise / allotmentUnited Heat TransferUnited Heat Transfer Limited approves half-year financial results for Sept 2026
- Fundraise / allotmentJubilant PharmovaJubilant Pharmova reports Q2 and H1 FY27 financial results and operational updates
- Fundraise / allotmentNatural CapsulesNatural Capsules Limited approves Q2 2026 results and preferential allotment
- Fundraise / allotmentNatural CapsulesNatural Capsules Ltd announces Q2 FY27 results and approves preferential allotment
- Fundraise / allotmentDestiny Logistics & InfraDestiny Logistics & Infra Ltd announces key resignations, appointments, and warrant lapse
- Fundraise / allotmentShalimar PaintsShalimar Paints Limited announces QIP Committee approval for equity shares issue
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.